Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVALT-8B: Adjuvant chemotherapy with or without nadroparin in resected high‑risk NSCLC
NL-OMON35584Phase 3Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of nadroparin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by University Medical Center Groningen. Started Nov 2007; status: active, not recruiting.
02
Drugs
nadroparin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NL-OMON35584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35584.